Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Shares Shorted: Short Interest Down 85.7% in September

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) saw a large decline in short interest in the month of September. As of September 15th, there was short interest totaling 204 shares, a decline of 85.7% from the August 31st total of 1,431 shares. Based on an average trading volume of 631 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.0% of the shares of the company are short sold.

Orion OYJ Price Performance

Shares of ORINY stock opened at $47.16 on Friday. The stock’s 50-day simple moving average is $44.30 and its 200-day simple moving average is $40.59. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64. The firm has a market capitalization of $13.31 billion, a PE ratio of 19.41 and a beta of 0.08. Orion OYJ has a fifty-two week low of $30.89 and a fifty-two week high of $47.16.

Orion OYJ (OTCMKTS:ORINY) last released its earnings results on Friday, July 17th. The company reported $0.58 EPS for the quarter. The firm had revenue of $606.38 million during the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%.

Orion OYJ Company Profile

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.